Baypointe Partners’s Colgate-Palmolive CL Stock Holding History

Baypointe Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$917K	Sell	10,000 -40,000	-80%	-$3.5M	2.2%	14
2026 Q1	$4.26M	Buy	+50,000	New	+$4.46M	5.85%	7
2025 Q4	–	Sell	-100,000	Closed	-$7.99M	–	17
2025 Q3	$7.99M	Buy	100,000 +87,500	+700%	+$7.46M	3.65%	14
2025 Q2	$1.14M	Sell	12,500 -87,500	-88%	-$7.99M	1.33%	21
2025 Q1	$9.37M	Buy	+100,000	New	+$8.95M	7.8%	6

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Baypointe Partners's CL Position: Q2 2026 in Review

Baypointe Partners reduced its Colgate-Palmolive (CL) stake by 80% in Q2 2026, selling an estimated $3.5M and leaving 10,000 shares worth $917K. The position accounts for 2.2% of the portfolio, ranked #14.

Baypointe Partners first reported a position in CL in Q1 2025 and has held it in 5 quarters since. The position peaked at $9.37M in Q1 2025. 2,004 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Baypointe Partners held 10,000 shares of Colgate-Palmolive worth $917K as of Q2 2026.
Baypointe Partners sold 40,000 Colgate-Palmolive shares in Q2 2026, an estimated $3.5M.
Colgate-Palmolive made up 2.2% of Baypointe Partners's portfolio in Q2 2026, its #14 holding.
Baypointe Partners first reported a position in Colgate-Palmolive in Q1 2025 and has held it in 5 quarters since.
Baypointe Partners's Colgate-Palmolive position peaked at $9.37M in Q1 2025.
2,004 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Baypointe Partners's 13F filing for Q2 2026, filed 30 Jul 2026.